Tenders/Supply of medicines – Adalimumab 2026

Supply of medicines – Adalimumab 2026

Auto-translated from cs
Original title: Dodávky léků – Adalimumab 2026
Revmatologický ústav
Published: Apr 24, 2026
Updated: Apr 28, 2026
Source: czech_nen

Summary

Translated
Ongoing supply of the medicinal product Adalimumab, classified under Antineoplastics and immunomodulators.

Description

Předmětem plnění jsou průběžné dodávky dle Přílohy č. 1 Kupní smlouvy – Cenová nabídka, v rozsahu a v souladu se zadávacími podmínkami a to dodávky léčivých přípravků adalimumab – L04AB04

Code from the NIPEZ code list

33652000-5

Name from the NIPEZ code list

Antineoplastika a imunomodulátory

About This Opportunity

This is a services contract in the health and medical services and general supplies sectors. Located in Czech Republic, Europe, this opportunity is open to firms and consortiums. Proposals must be submitted before May 29, 2026.

Published through Czech Republic NEN, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for services in the health and medical services sector. Service contracts are typically evaluated on both technical quality and price, and may require bidders to demonstrate relevant experience and qualified personnel. Interested parties should review the full documentation on the original source before submitting their proposal.

Key Details

Submission Deadline
May 29, 2026
32 days remaining
Contract Type
Services
Eligibility
Firms / Consortiums
Language
cs

Source

czech_nen
czech_nen
Official Source

Contracting Authority

Revmatologický ústav
🇨🇿Czech Republic

Contact

Matching Experts

Are you a consultant?

Join our Expert Network and get matched with relevant tenders.